Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Endometriosis | 6 | 2025 | 58 | 3.130 |
Why?
|
| Pelvic Pain | 5 | 2025 | 42 | 2.260 |
Why?
|
| Uterine Neoplasms | 4 | 2024 | 98 | 2.180 |
Why?
|
| Hysterectomy | 6 | 2025 | 138 | 2.110 |
Why?
|
| Laparoscopy | 5 | 2023 | 481 | 1.690 |
Why?
|
| Uterine Diseases | 2 | 2026 | 18 | 1.670 |
Why?
|
| Leiomyoma | 3 | 2024 | 61 | 1.550 |
Why?
|
| Postoperative Complications | 7 | 2026 | 2977 | 1.510 |
Why?
|
| Pelvic Floor Disorders | 2 | 2025 | 16 | 1.120 |
Why?
|
| Ovarian Neoplasms | 3 | 2022 | 595 | 1.030 |
Why?
|
| Cesarean Section | 2 | 2026 | 230 | 0.930 |
Why?
|
| Cicatrix | 1 | 2026 | 69 | 0.890 |
Why?
|
| Neuromuscular Agents | 2 | 2025 | 46 | 0.880 |
Why?
|
| Botulinum Toxins, Type A | 2 | 2025 | 60 | 0.860 |
Why?
|
| Obstetrics | 2 | 2026 | 177 | 0.800 |
Why?
|
| Gynecologic Surgical Procedures | 2 | 2021 | 67 | 0.800 |
Why?
|
| Uterine Myomectomy | 2 | 2020 | 7 | 0.800 |
Why?
|
| Gynecology | 2 | 2026 | 181 | 0.790 |
Why?
|
| Chronic Pain | 2 | 2025 | 292 | 0.780 |
Why?
|
| Pregnancy, Interstitial | 1 | 2023 | 1 | 0.770 |
Why?
|
| Adenomyoma | 1 | 2022 | 2 | 0.740 |
Why?
|
| Uterine Cervical Diseases | 1 | 2022 | 6 | 0.740 |
Why?
|
| Cystectomy | 1 | 2021 | 42 | 0.680 |
Why?
|
| Ovariectomy | 1 | 2021 | 166 | 0.660 |
Why?
|
| Uterine Perforation | 1 | 2020 | 4 | 0.640 |
Why?
|
| Uterine Inertia | 1 | 2020 | 3 | 0.640 |
Why?
|
| Dilatation and Curettage | 1 | 2020 | 13 | 0.640 |
Why?
|
| Surgeons | 2 | 2022 | 340 | 0.630 |
Why?
|
| Pregnancy Rate | 1 | 2020 | 81 | 0.630 |
Why?
|
| Uterine Hemorrhage | 1 | 2020 | 41 | 0.620 |
Why?
|
| Laparotomy | 1 | 2020 | 113 | 0.620 |
Why?
|
| Minimally Invasive Surgical Procedures | 1 | 2021 | 189 | 0.600 |
Why?
|
| Venous Thromboembolism | 1 | 2024 | 328 | 0.600 |
Why?
|
| Elective Surgical Procedures | 1 | 2021 | 203 | 0.580 |
Why?
|
| Clinical Protocols | 1 | 2021 | 280 | 0.580 |
Why?
|
| Mentoring | 1 | 2022 | 166 | 0.570 |
Why?
|
| Abortion, Induced | 1 | 2020 | 111 | 0.540 |
Why?
|
| Fellowships and Scholarships | 1 | 2021 | 354 | 0.500 |
Why?
|
| Gestational Age | 1 | 2020 | 989 | 0.490 |
Why?
|
| Female | 24 | 2026 | 79035 | 0.460 |
Why?
|
| Hysteroscopy | 3 | 2023 | 14 | 0.430 |
Why?
|
| Pregnancy | 6 | 2026 | 7215 | 0.390 |
Why?
|
| Humans | 25 | 2026 | 145763 | 0.340 |
Why?
|
| Retrospective Studies | 8 | 2026 | 17325 | 0.340 |
Why?
|
| Databases, Factual | 3 | 2026 | 1491 | 0.280 |
Why?
|
| Risk Factors | 4 | 2026 | 10917 | 0.280 |
Why?
|
| Incidence | 2 | 2026 | 2933 | 0.270 |
Why?
|
| Hysterectomy, Vaginal | 1 | 2026 | 6 | 0.240 |
Why?
|
| United States | 5 | 2025 | 16123 | 0.230 |
Why?
|
| Pelvic Floor | 1 | 2025 | 32 | 0.220 |
Why?
|
| Adult | 8 | 2026 | 40872 | 0.220 |
Why?
|
| Time Factors | 4 | 2026 | 7133 | 0.220 |
Why?
|
| Injections, Intramuscular | 1 | 2025 | 146 | 0.220 |
Why?
|
| Workload | 1 | 2026 | 169 | 0.200 |
Why?
|
| Sterilization, Tubal | 1 | 2023 | 17 | 0.190 |
Why?
|
| Struma Ovarii | 1 | 2022 | 8 | 0.180 |
Why?
|
| Residence Characteristics | 1 | 2025 | 375 | 0.180 |
Why?
|
| Salpingo-oophorectomy | 1 | 2022 | 19 | 0.180 |
Why?
|
| Adenocarcinoma, Follicular | 1 | 2022 | 43 | 0.180 |
Why?
|
| Education, Continuing | 1 | 2022 | 42 | 0.170 |
Why?
|
| Ambulatory Surgical Procedures | 1 | 2022 | 79 | 0.170 |
Why?
|
| Physical Therapy Modalities | 1 | 2025 | 337 | 0.170 |
Why?
|
| Premenopause | 1 | 2021 | 125 | 0.170 |
Why?
|
| Socioeconomic Factors | 1 | 2025 | 1327 | 0.160 |
Why?
|
| Evidence-Based Medicine | 1 | 2025 | 740 | 0.160 |
Why?
|
| Gonadotropin-Releasing Hormone | 1 | 2022 | 217 | 0.160 |
Why?
|
| Abortifacient Agents | 1 | 2020 | 4 | 0.160 |
Why?
|
| Quality of Health Care | 1 | 2025 | 693 | 0.160 |
Why?
|
| San Francisco | 1 | 2020 | 60 | 0.160 |
Why?
|
| Diagnosis, Differential | 1 | 2025 | 1512 | 0.160 |
Why?
|
| Cervix Uteri | 1 | 2020 | 50 | 0.160 |
Why?
|
| Urban Health Services | 1 | 2020 | 69 | 0.160 |
Why?
|
| Lacerations | 1 | 2020 | 40 | 0.150 |
Why?
|
| Postoperative Hemorrhage | 1 | 2020 | 105 | 0.150 |
Why?
|
| Patient Reported Outcome Measures | 1 | 2023 | 498 | 0.140 |
Why?
|
| Cost-Benefit Analysis | 1 | 2022 | 644 | 0.140 |
Why?
|
| Intraoperative Complications | 1 | 2020 | 157 | 0.140 |
Why?
|
| Ultrasonography | 1 | 2023 | 788 | 0.140 |
Why?
|
| Operative Time | 1 | 2019 | 181 | 0.140 |
Why?
|
| Needs Assessment | 1 | 2021 | 403 | 0.140 |
Why?
|
| Blood Transfusion | 1 | 2021 | 409 | 0.140 |
Why?
|
| Thyroid Neoplasms | 1 | 2022 | 370 | 0.130 |
Why?
|
| Clinical Competence | 2 | 2026 | 1247 | 0.130 |
Why?
|
| Pregnancy Outcome | 1 | 2020 | 504 | 0.130 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2023 | 1751 | 0.120 |
Why?
|
| Surgical Wound Infection | 1 | 2020 | 329 | 0.120 |
Why?
|
| Pain | 1 | 2022 | 791 | 0.120 |
Why?
|
| Societies, Medical | 1 | 2021 | 900 | 0.120 |
Why?
|
| Robotic Surgical Procedures | 1 | 2019 | 185 | 0.120 |
Why?
|
| Medicare | 1 | 2022 | 904 | 0.120 |
Why?
|
| Patient Readmission | 1 | 2021 | 772 | 0.120 |
Why?
|
| Thoracic Outlet Syndrome | 1 | 2015 | 14 | 0.110 |
Why?
|
| Ribs | 1 | 2015 | 35 | 0.110 |
Why?
|
| Logistic Models | 1 | 2020 | 2139 | 0.110 |
Why?
|
| Decompression, Surgical | 1 | 2015 | 116 | 0.100 |
Why?
|
| Middle Aged | 4 | 2025 | 36302 | 0.100 |
Why?
|
| Osteotomy | 1 | 2015 | 129 | 0.100 |
Why?
|
| Aged | 2 | 2025 | 26215 | 0.100 |
Why?
|
| Cohort Studies | 1 | 2024 | 6032 | 0.100 |
Why?
|
| Risk Assessment | 1 | 2021 | 3752 | 0.090 |
Why?
|
| Quality of Life | 1 | 2023 | 3210 | 0.080 |
Why?
|
| Mental Disorders | 1 | 2020 | 1169 | 0.080 |
Why?
|
| Treatment Outcome | 3 | 2021 | 11793 | 0.080 |
Why?
|
| Substance-Related Disorders | 1 | 2020 | 1102 | 0.080 |
Why?
|
| Hospitalization | 1 | 2020 | 2460 | 0.080 |
Why?
|
| Young Adult | 2 | 2020 | 14251 | 0.060 |
Why?
|
| Urinary Bladder, Overactive | 1 | 2025 | 23 | 0.050 |
Why?
|
| Adolescent | 2 | 2022 | 22573 | 0.050 |
Why?
|
| Urinary Incontinence | 1 | 2025 | 65 | 0.050 |
Why?
|
| Pelvic Organ Prolapse | 1 | 2025 | 62 | 0.050 |
Why?
|
| Fecal Incontinence | 1 | 2025 | 90 | 0.050 |
Why?
|
| Age Factors | 2 | 2025 | 3346 | 0.050 |
Why?
|
| Device Removal | 1 | 2023 | 142 | 0.040 |
Why?
|
| Preoperative Period | 1 | 2019 | 149 | 0.040 |
Why?
|
| Models, Theoretical | 1 | 2019 | 560 | 0.030 |
Why?
|
| Baltimore | 1 | 2015 | 72 | 0.030 |
Why?
|
| Internship and Residency | 1 | 2026 | 1269 | 0.030 |
Why?
|
| Lidocaine | 1 | 2015 | 55 | 0.030 |
Why?
|
| Injections | 1 | 2015 | 199 | 0.030 |
Why?
|
| Anesthetics, Local | 1 | 2015 | 104 | 0.030 |
Why?
|
| Nerve Block | 1 | 2015 | 108 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2026 | 8075 | 0.020 |
Why?
|
| Recovery of Function | 1 | 2015 | 716 | 0.020 |
Why?
|
| Prognosis | 1 | 2019 | 4329 | 0.020 |
Why?
|
| Length of Stay | 1 | 2015 | 1350 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2019 | 5922 | 0.020 |
Why?
|
| Analgesics, Opioid | 1 | 2015 | 1154 | 0.010 |
Why?
|
| Male | 1 | 2015 | 73003 | 0.000 |
Why?
|